Article Details
Retrieved on: 2022-09-30 18:34:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Now, Roche is also testing an Alzheimer's treatment with a similar objective to cut down on beta amyloid levels in the brain. While Biogen's share ...
Article found on: www.forbes.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here